Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov;33(11):107423.
doi: 10.1016/j.jdiacomp.2019.107423. Epub 2019 Sep 3.

Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease

Jinnie J Rhee  1 , Jialin Han  2 , Maria E Montez-Rath  2 , Sun H Kim  3 , Mark R Cullen  4 , Randall S Stafford  5 , Wolfgang C Winkelmayer  6 , Glenn M Chertow  7
Affiliations

Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease

Jinnie J Rhee et al. J Diabetes Complications. 2019 Nov.

Abstract

Aims: To quantify patterns of conventional and newer antidiabetic medication use in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD).

Methods: We used data from a large claims and integrated dataset that includes employed and commercially insured patients in the US to select patients who had T2DM and CKD with information on laboratory values and prescriptions for antidiabetic medications from January 1, 2014 to January 1, 2015. We stratified the analyses by sociodemographic variables.

Results: In a cohort of 38,577 patients with T2DM and CKD, we found wide variation in the treatment of T2DM by CKD stage as well as by several sociodemographic factors. Although metformin was the most commonly prescribed medication, only about half of patients in the cohort and fewer than two-thirds of patients with early stage CKD were prescribed metformin. Approximately 10.6% of patients with CKD stage 4 and 2.1% of the patients with CKD stage 5 were prescribed metformin. Sulfonylureas with active metabolites that accumulate with impaired kidney function were prescribed in more than one-third of patients with CKD stages 3b, 4, and 5. Only 3.4% and 12.3% of patients were prescribed GLP-1 and DPP-4 respectively.

Conclusions: Prescriptions for metformin were lower than expected among patients with mild to moderate CKD. Prescriptions for newer antidiabetic medications with known safety and efficacy across the spectrum of CKD remained low. Prescriptions for agents contraindicated in advanced CKD continued to be written in a sizeable fraction of patients.

Keywords: Antidiabetic medications; Chronic kidney disease; Type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

Declarations of interest: none

Figures

Figure 1.
Figure 1.
Cohort assembly of patients age ≥18 years with T2DM and CKD in The Clinformatics Data Mart, Optumlnsight Life sciences database (Optumlnsight, Eden, Prairie, MN) in 2015
See this image and copyright information in PMC

References

    1. American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care. 2013;36(Suppl 1):S11–66. - PMC - PubMed
    1. Calisti L, Tognetti S. Measure of glycosylated hemoglobin. Acta Biomed. 2005;76 Suppl 3:59–62. - PubMed
    1. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, et al. Cardiac calcification in adult hemodialysis patients: A link between end-stage renal disease and cardiovascular disease? JAm Coll Cardiol. 2002;39(4):695–701. - PubMed
    1. Floege J, Raggi P, Block GA, Torres PU, Csiky B, Naso A, et al. Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients. Nephrol Dial Transplant. 2010. June;25(6): 1916–23. - PubMed
    1. Chen NX, Duan D, O’Neill KD, Moe SM. High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant. 2006;21(12):3435–3442. - PubMed

Publication types

MeSH terms

Substances